Feature

Article

Pharmaceutical Executive

Pharmaceutical Executive: June 2024
Volume44
Issue 6

Pharmaceutical Executive: June 2024 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive June 2024 issue in an interactive PDF format.

June 2024
Download Issue PDF
Articles in this issue
Beyond the Numbers: Extrapolating Today’s Trends Forward
Beyond the Numbers: Extrapolating Today’s Trends Forward
Pharmaceutical Executive: June 2024 Issue (PDF)
Pharmaceutical Executive: June 2024 Issue (PDF)
Opposite Spectrums
Opposite Spectrums
2024 Pharm Exec Top 50 Companies
2024 Pharm Exec Top 50 Companies
Craig Tooman: Silencing the Distractions
Craig Tooman: Silencing the Distractions
Regaining Trust in the Pharma Industry
Regaining Trust in the Pharma Industry

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Peter Rubin
Related Content
President Donald Trump
September 30th 2025

President Trump to Announce Government Run Direct-to-Patient Pharmaceutical Website: Report

Mike Hollan
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 29, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

AstraZeneca Announces Plans to Harmonize Global Listing Structure for Stock Exchanges Alongside Positive Enhertu Updates

Mike Hollan
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 26, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

Genmab Acquires Merus in $8 Billion Transaction Agreement Including Late-Stage Breakthrough Therapy Asset Petosemtamab

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

GSK Announces Luke Miels as Company’s Next CEO

Nicholas Jacobus
© 2025 MJH Life Sciences

All rights reserved.